Share on StockTwits

Omnicell (NASDAQ:OMCL) CFO Robin Gene Seim unloaded 27,500 shares of the company’s stock on the open market in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $28.19, for a total transaction of $775,225.00. Following the completion of the sale, the chief financial officer now directly owns 77,150 shares of the company’s stock, valued at approximately $2,174,859. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

A number of research firms have recently commented on OMCL. Analysts at Topeka Capital Markets raised their price target on shares of Omnicell from $30.00 to $31.00 in a research note on Thursday, August 28th. They now have a “buy” rating on the stock. Separately, analysts at Zacks upgraded shares of Omnicell from a “neutral” rating to an “outperform” rating in a research note on Friday, August 8th. They now have a $32.00 price target on the stock. Seven analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus price target of $31.43.

Shares of Omnicell (NASDAQ:OMCL) traded up 0.46% on Thursday, hitting $28.27. 54,080 shares of the company’s stock traded hands. Omnicell has a 52-week low of $20.88 and a 52-week high of $30.33. The stock has a 50-day moving average of $27. and a 200-day moving average of $27.55. The company has a market cap of $1.014 billion and a P/E ratio of 36.17.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.01. The company had revenue of $105.10 million for the quarter, compared to the consensus estimate of $103.23 million. During the same quarter in the previous year, the company posted $0.27 earnings per share. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. Analysts expect that Omnicell will post $1.23 EPS for the current fiscal year.

Omnicell, Inc (NASDAQ:OMCL) is a provider of automated solutions for hospital medication and supply management.

Receive News & Ratings for Omnicell Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.